Cardillo, Thomas M; Karacay, Habibe; Goldenberg, David M et al. (2004) Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy. Clin Cancer Res 10:3552-61
|
Gold, David V; Modrak, David E; Schutsky, Keith et al. (2004) Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft. Int J Cancer 109:618-26
|
Gold, David V; Schutsky, Keith; Modrak, David et al. (2003) Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancer. Clin Cancer Res 9:3929S-37S
|
Reddy, P K; Gold, D V; Cardillo, T M et al. (2003) Interferon-gamma upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA induction. Eur J Cancer 39:397-404
|
Cardillo, Thomas M; Blumenthal, Rosalyn; Ying, Zhiliang et al. (2002) Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer. Int J Cancer 97:386-92
|
Hajjar, George; Sharkey, Robert M; Burton, Jack et al. (2002) Phase I radioimmunotherapy trial with iodine-131--labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer. Clin Colorectal Cancer 2:31-42
|
Modrak, David E; Rodriguez, Marisol D; Goldenberg, David M et al. (2002) Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenografts. Int J Oncol 20:379-84
|
O'Hara, J A; Blumenthal, R D; Grinberg, O Y et al. (2001) Response to radioimmunotherapy correlates with tumor pO2 measured by EPR oximetry in human tumor xenografts. Radiat Res 155:466-73
|
Gold, D V; Cardillo, T M (2001) Monoclonal antibody G47 engineered to be reactive with colorectal tumor mucin. Hybrid Hybridomics 20:343-50
|
Gold, D V; Cardillo, T; Goldenberg, D M et al. (2001) Localization of pancreatic cancer with radiolabeled monoclonal antibody PAM4. Crit Rev Oncol Hematol 39:147-54
|
Showing the most recent 10 out of 32 publications